2011
DOI: 10.1111/j.1440-1843.2011.02075.x
|View full text |Cite
|
Sign up to set email alerts
|

Increased natural killer T‐like cells are a major source of pro‐inflammatory cytokines and granzymes in lung transplant recipients

Abstract: Current therapeutics is inadequate at suppressing NKT-like cell numbers and their production of pro-inflammatory mediators known to be associated with graft rejection. Alternative therapies that specifically target NKT-like cells may improve patient morbidity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
48
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 37 publications
(51 citation statements)
references
References 20 publications
3
48
0
Order By: Relevance
“…14 We previously showed lack of modulation of granzyme B in T, NK, and NKT-like cells in the presence of therapeutic doses of cyclosporine, tacrolimus, or prednisolone, suggesting other strategies are necessary to reduce these cytotoxic molecules. 5 In this regard, we recently showed inhibition of T-cell granzyme B production in the presence of gabexate mesylate in vitro, and this compound may also be a suitable therapeutic agent to reduce granzyme B production by NKT-like cells and possibly NK cells. 3 Further, inhibition of pro-inflammatory cytokines in vitro was more effective for patient's T-cells than NKT-like cells, suggesting possible resistance of NKT-like cells to therapy.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…14 We previously showed lack of modulation of granzyme B in T, NK, and NKT-like cells in the presence of therapeutic doses of cyclosporine, tacrolimus, or prednisolone, suggesting other strategies are necessary to reduce these cytotoxic molecules. 5 In this regard, we recently showed inhibition of T-cell granzyme B production in the presence of gabexate mesylate in vitro, and this compound may also be a suitable therapeutic agent to reduce granzyme B production by NKT-like cells and possibly NK cells. 3 Further, inhibition of pro-inflammatory cytokines in vitro was more effective for patient's T-cells than NKT-like cells, suggesting possible resistance of NKT-like cells to therapy.…”
Section: Discussionmentioning
confidence: 98%
“…3 Further, inhibition of pro-inflammatory cytokines in vitro was more effective for patient's T-cells than NKT-like cells, suggesting possible resistance of NKT-like cells to therapy. 5 Interestingly, inhibition of IFN-␥ and TNF-␣ by NK cells in blood from stable patients was more effective using these therapeutic agents than T or NKT-like cells, and future experiments are planned to investigate possible drug resistance by NK cells in patients with BOS.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…One hundred and fifty microlitres of peripheral blood were stained with monoclonal antibodies as reported previously to CD8 fluorescein isothiocyanate (FITC) (BD Biosciences (BD), Sydney, Australia), CD4 phycoerythrin (PE) (BD), CD3 peridinin chlorophyll-cyanine 5·5 (PerCP-Cy5·5) (BD), CD28 PE-Cy7 (BD) and CD45V450 (BD) and analysed as reported previously [8,10,13].…”
Section: Cd3 Cd4 Cd8 and Cd28 Expression By T Cell Subsetsmentioning
confidence: 99%
“…Down-regulation of CD28 expression following persistent antigenic stimulation has also been shown to be associated with up-regulation of CD57 expression, a terminally sulphated carbohydrate determinant found on subsets of natural killer (NK) cells and NK T-like cells associated with ageing [9]. Interestingly, we have shown recently that there are increased peripheral blood CD56 + CD3 + NK T-like cells in blood from stable lung transplant patients and that these cells exhibit increased production of proinflammatory cytokines interferon (IFN)-g and tumour necrosis factor (TNF)-a and expression of cytotoxic molecules, perforin and granzymes [10]. We hypothesized that dysregulated expression of T cell co-stimulatory molecules may be associated with steroid resistance and BOS, and identify potential new therapeutic targets that are needed urgently to improve the morbidity and mortality rates following lung transplantation.…”
Section: Introductionmentioning
confidence: 99%